Marie-christine C. Bouedec-Le

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study.

Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study.

Journal: Journal of the American Academy of Dermatology

Published: June 12, 2023

Hand eczema in glove-wearing patients.

Hand eczema in glove-wearing patients.

Journal: Contact dermatitis

Published: February 08, 2023

Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients.

Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 01, 2022

Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children.

Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children.

Journal: Contact dermatitis

Published: November 13, 2021

Rapid Desensitization to Adalimumab Is Associated With Decreased Basophil Sensitivity.

Rapid Desensitization to Adalimumab Is Associated With Decreased Basophil Sensitivity.

Journal: Journal of investigational allergology & clinical immunology

Published: April 25, 2019

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.

Journal: Journal of the American Academy of Dermatology

Published: October 30, 2018

Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.

Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.

Journal: The British journal of dermatology

Published: June 17, 2018

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Journal: The Journal of investigative dermatology

Published: May 02, 2018

Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.

Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 02, 2016

Alkyl Glucosides in Contact Dermatitis.

Alkyl Glucosides in Contact Dermatitis.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: October 25, 2016

Outbreak of contact sensitization to methylisothiazolinone: an analysis of French data from the REVIDAL-GERDA network.

Outbreak of contact sensitization to methylisothiazolinone: an analysis of French data from the REVIDAL-GERDA network.

Journal: Contact dermatitis

Published: September 26, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026